富血小板血浆裂解液联合接骨药丸治疗胫腓骨骨不连
DOI:
作者:
作者单位:

山东省文登整骨医院

作者简介:

通讯作者:

中图分类号:

基金项目:

第三批威海市重点专科(创伤科)


Treatment of nonunion of tibia and fibula with platelet-rich plasma lysate and bone-setting pills
Author:
Affiliation:

Shandong Wendeng Orthopedic Hospital

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    [目的] 探讨富血小板血浆裂解液联合接骨药丸治疗胫腓骨骨不连的临床疗效。[方法] 2019年1月至2022年1月本院收治的46例胫腓骨骨不连患者,其中男34例,女8例;年龄45~62岁,中位数53.5岁;46例患者随机分为富血小板血浆裂解液组(对照组)和富血小板血浆裂解液联合接骨药丸治疗组(治疗组),每组23例。记录两组患者的年龄、性别、病程等基本情况。两组患者都从肘静脉处抽取100ml的静脉血用于制备富血小板血浆血浆。制备完成后于-20℃冰箱冷冻,解冻离心后制备富血小板血浆裂解液,并检测富血小板血浆裂解液中的成分及含量。富血小板血浆裂解液联合接骨药丸治疗组治疗后给予口服接骨药丸一个月且期间不能同时服用任何其他药物。分别于治疗前和治疗结束后2个月、3个月、4个月、6个月,采用骨痂和骨折线影像学评分标准在X线片上评价骨折愈合情况,观察并发症发生情况。[结果] ⑴富血小板血浆细胞因子检测结果。制备的患者自体富血小板血浆中,细胞因子VEGF和TGF-β的含量分别为(583.87±23.51)pg·mL-1和(195.73±26.08)pg·mL-1。⑵影像评价。所有患者均获随访,随访时间3~6个月,中位数4个月。治疗前,2组患者骨痂影像学评分组间比较,差异无统计学意义(P>0.05);治疗结束后2个月、治疗结束后3个月、治疗结束后4个月、治疗结束后6个月,治疗组骨痂影像学评分均高于对照组。2组患者骨痂影像学评分组间比较,差异有统计学意义(P<0.05)。治疗前,2组患者骨折线影像学评分组间比较,差异无统计学意义(P>0.05);治疗结束后2个月、治疗结束后3个月、治疗结束后4个月、治疗结束后6个月,治疗组骨折线影像学评分均高于对照组,2组患者骨折线影像学评分组间比较,差异有统计学意义(P<0.05)。44例患者达到骨性愈合标准,骨不连愈合时间3~6个月,中位数3.5个月,未愈合患者行其它治疗。所有患者均无血管、神经损伤等并发症。[结论] 富血小板血浆裂解液联合接骨药丸治疗胫腓骨骨不连疗效确切,具有较好的应用前景。

    Abstract:

    [Objective]To investigate the clinical efficacy of platelet-rich plasma lysate combined with Jiegu Pill in the treatment of nonunion of tibia and fibula. [Methods]From Januaryuary 2019 to Januaryuary 2022,46 cases of tibiofibular nonunion were treated in our hospital,including 34 males and 8 females,aged 45-62 years (median 53.5 years);Forty-six patients were randomly divided into platelet-rich plasma lysate group (control group,) and platelet-rich plasma lysate combined with Jiegu Pill Group (treatment group,).The age,sex and course of disease were recorded.In both groups, 100 ml of venous blood was drawn from the elbow vein to prepare platelet-rich plasma.The lysates of platelet-rich plasma were prepared by thawing and centrifugation.The components and contents of lysates of platelet-rich plasma were determined.In the treatment group,the platelet-rich plasma lysate combined with Jiegu pill was given orally Jiegu pill for one month without taking any other drugs.The Healing of fracture was evaluated on X-ray before and 2,3,4,6 months after treatment by callus and fracture line imaging scoring system,observe the occurrence of complications.[Results](1)Detection of platelet-rich plasma cytokines. The levels of cytokines VEGF and TGF-β were (583.87±23.51)pg·ml-1 and (195.73±26.08)pg·ml-1.(2)Image evaluation.All patients were followed up for a median of 4 months (range,3-6 months).Before treatment,there was no significant difference in callus imaging score between the two groups(P > 0.05) Two months after treatment,three months, four months and six months after treatment,the callus imaging scores of the treatment group were higher than those of the control group.There was significant difference in callus imaging score between the two groups (P < 0.05).Before treatment,there was no significant difference in fracture line imaging score between the two groups (P > 0.05).Two months after treatment,three months after treatment,four months after treatment and six months after treatment,the scores of fracture line in the treatment group were higher than those in the control group,there was significant difference between the two groups in fracture line imaging score (P < 0.05).Forty-four patients achieved bone union.The time of nonunion union was 3-6 months (median 3.5 months).All patients had no vascular and nerve injury and other complications. [Conclusion]The treatment of nonunion of tibia and fibula with platelet-rich plasma lysate combined with Jiegu pill is effective and has a good application prospect.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-05-30
  • 最后修改日期:2023-05-30
  • 录用日期:2023-06-25
  • 在线发布日期:
  • 出版日期: